CAROLINE KIMBROUGH: Open Payments
NPI 1255872115 · ROCHESTER, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 35 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $213 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $239 |
| AstraZeneca Pharmaceuticals LP | 11 | $232 |
| Amgen Inc. | 3 | $75 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| Genentech USA, Inc. | 4 | $68 |
| Lilly USA, LLC | 1 | $27 |
Products named: TREMFYA, SAPHNELO, ACTHAR, Actemra, OTEZLA, KRYSTEXXA, TALTZ.
Industry payments across MN — which companies pay providers there.
